69
Genor BioPharma
6998.HK·HKEXShanghai CNFounded 2017500 employees
Small CapbiotechPublicOncologyHematology
Platform: GB261 Bispec
Market Cap
$0.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (6998.HK)
Loading 6998.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Pexasacituzumab | 699-7180 | Preclinical | 2 | USP1 | LGS | ||
| 699-6202 | 699-6202 | Phase 1/2 | 2 | TROP-2 | Heart FailureT2D |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Genor BioPharma trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)